Company profile
Telescope Innovations Corp.
OTC: TELIF · Healthcare · Biotechnology
Canadian filerHQ Vancouver, BCReports USD
#737 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
——FH 51DQ —GM —SS 27
v0.1 · 35/100 weight · pillars only
↑ revenue growth (YoY), Altman-Z · ↓ listing tenure, workforce scale
Methodology →Revenue TTM
$5.3M
Rev growth YoY (TTM)
+67.2%
Net income (FY)
-$1.1M
Employees
5
as of 2026-08-20
Market cap
$26.3M
as of 2026-08-20
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$3.4M4.8M CAD2025
Net income-$1.1M-1.6M CAD2025
Operating income-$965.4k-1.3M CAD2025
Total assets$5.3M7.3M CAD2025
Liabilities$3.8M5.3M CAD2025
Equity$1.5M2.0M CAD2025
Revenue trend
FY2020 – FY2025 · USD
FY20
FY21
FY22
FY23
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Telescope Innovations Corp.’s revenue?
Telescope Innovations Corp. booked $3.4M in FY2025 revenue, growing 63% year over year — faster than most Healthcare companies we track, at a -32.7% net margin.
Peers · Healthcare
SheerVision, Inc.——CAMP4 Therapeutics Corporation27DSurrozen, Inc.30DCaliber Imaging & Diagnostics, Inc.——United American Healthcare Corporation——Nuo Therapeutics, Inc.48DKey facts
CEOHenry Dubina
SectorHealthcare
IndustryBiotechnology
HeadquartersVancouver, BC
ExchangeOTC: TELIF
Employees5
IPO date2022-05-24
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.